Innovation is at the core of what we do
We are a molecular life science company dedicated to advancing human health through innovation. By designing and building breakthrough molecular platforms that are both accessible and best-in-class, One BioMed is providing biomedical researchers and clinicians with unprecedented access to cutting-edge tools.
One BioMed launches the cartridge-based Xceler8™ Nucleic Acid Extraction Platform, the next generation in workflow simplification.
Southeast Asia’s top 50 rising women in tech 2021
Innovating a diagnostic device that detects infectious diseases within 30 minutes
PULSE by Maeil Business News Korea
JW Bioscience invests in Singapore’s molecular diagnostic firm One BioMed
One BioMed offers cutting-edge medical diagnostic platform
Healthcare Startup One BioMed closes $5M Series A
Asian Scientist Magazine
One kit to test for 20 diseases In 20 minutes
One BioMed & A*STAR launch $9M joint lab to make diagnostic kit for infectious diseases
Biotech expected to be key driver of future economy
One BioMed and Genome Institute of Singapore establish joint laboratory for the development of novel Point-of-Care molecular diagnostics platform